Sika Valuation

Q: What is the Fair Price of SIKAZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

SIKAZ (CHF245.2) is trading below our estimate of [[fair value]] (CHF271.7)

Is SIKAZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SIKAZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SIKAZ (CHF245.2) is trading below our estimate of fair value (CHF271.7)

Significantly Below Fair Value: SIKAZ is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SIKAZ?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for SIKAZ. This is calculated by dividing SIKAZ's market cap by their current preferred multiple.
What is SIKAZ's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

SIKAZ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.9x
Enterprise Value/EBITDA	19.3x
PEG Ratio	3.5x

Price to Earnings Ratio vs Peers

How does SIKAZ's PE Ratio compare to its peers?

The above table shows the PE ratio for SIKAZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	25.7x
CRDA Croda International	31.1x	15.5%	UK£5.3b
JMAT Johnson Matthey	23.9x	28.4%	UK£2.6b
VCT Victrex	23.8x	37.8%	UK£740.9m
TET Treatt	24x	15.3%	UK£276.3m
SIKAZ Sika	31.5x	9.0%	CHF 39.3b

Price-To-Earnings vs Peers: SIKAZ is expensive based on its Price-To-Earnings Ratio (31.5x) compared to the peer average (26.3x).

Price to Earnings Ratio vs Industry

How does SIKAZ's PE Ratio compare vs other companies in the European Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	28.0%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	28.0%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: SIKAZ is expensive based on its Price-To-Earnings Ratio (31.5x) compared to the European Chemicals industry average (17.7x).

Price to Earnings Ratio vs Fair Ratio

What is SIKAZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SIKAZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	31.5x
Fair PE Ratio	19.8x

Price-To-Earnings vs Fair Ratio: SIKAZ is expensive based on its Price-To-Earnings Ratio (31.5x) compared to the estimated Fair Price-To-Earnings Ratio (19.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SIKAZ forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CHF 239.10	CHF 289.86 +21.2%	12.0%	CHF 350.00	CHF 220.00	n/a	21
Nov ’25	CHF 243.00	CHF 291.76 +20.1%	13.0%	CHF 370.00	CHF 220.00	n/a	21
Oct ’25	CHF 276.90	CHF 298.48 +7.8%	12.4%	CHF 370.00	CHF 230.00	n/a	21
Sep ’25	CHF 273.40	CHF 296.00 +8.3%	12.8%	CHF 380.00	CHF 230.00	n/a	22
Aug ’25	CHF 267.20	CHF 295.00 +10.4%	13.0%	CHF 380.00	CHF 230.00	n/a	22
Jul ’25	CHF 254.90	CHF 295.68 +16.0%	12.8%	CHF 380.00	CHF 230.00	n/a	22
Jun ’25	CHF 275.20	CHF 294.48 +7.0%	13.1%	CHF 380.00	CHF 230.00	n/a	21
May ’25	CHF 263.20	CHF 293.76 +11.6%	13.2%	CHF 380.00	CHF 230.00	n/a	21
Apr ’25	CHF 269.50	CHF 290.85 +7.9%	14.6%	CHF 390.00	CHF 224.00	n/a	20
Mar ’25	CHF 258.45	CHF 288.19 +11.5%	14.5%	CHF 390.00	CHF 224.00	n/a	21
Feb ’25	CHF 239.45	CHF 285.10 +19.1%	15.2%	CHF 390.00	CHF 230.00	n/a	21
Jan ’25	CHF 273.70	CHF 283.19 +3.5%	16.1%	CHF 380.00	CHF 225.00	n/a	21
Dec ’24	CHF 236.00	CHF 281.10 +19.1%	16.6%	CHF 380.00	CHF 223.00	n/a	21
Nov ’24	CHF 215.90	CHF 282.43 +30.8%	16.2%	CHF 380.00	CHF 223.00	CHF 243.00	21
Oct ’24	CHF 233.30	CHF 298.50 +27.9%	12.9%	CHF 380.00	CHF 230.00	CHF 276.90	21
Sep ’24	CHF 247.10	CHF 300.09 +21.4%	13.0%	CHF 380.00	CHF 228.00	CHF 273.40	22
Aug ’24	CHF 270.40	CHF 300.00 +10.9%	13.8%	CHF 390.00	CHF 228.00	CHF 267.20	21
Jul ’24	CHF 256.10	CHF 304.05 +18.7%	14.8%	CHF 390.00	CHF 228.00	CHF 254.90	21
Jun ’24	CHF 248.30	CHF 298.88 +20.4%	14.3%	CHF 390.00	CHF 228.00	CHF 275.20	21
May ’24	CHF 245.60	CHF 295.43 +20.3%	14.3%	CHF 390.00	CHF 228.00	CHF 263.20	20
Apr ’24	CHF 255.10	CHF 293.95 +15.2%	17.3%	CHF 390.00	CHF 162.95	CHF 269.50	22
Mar ’24	CHF 260.30	CHF 292.13 +12.2%	17.6%	CHF 390.00	CHF 162.95	CHF 258.45	22
Feb ’24	CHF 258.80	CHF 277.59 +7.3%	16.4%	CHF 380.00	CHF 162.95	CHF 239.45	22
Jan ’24	CHF 222.30	CHF 280.81 +26.3%	20.0%	CHF 420.00	CHF 162.95	CHF 273.70	21
Dec ’23	CHF 244.40	CHF 281.00 +15.0%	20.0%	CHF 420.00	CHF 162.95	CHF 236.00	21
Nov ’23	CHF 222.90	CHF 280.02 +25.6%	20.2%	CHF 420.00	CHF 162.95	CHF 215.90	21

Analyst Forecast: Target price is less than 20% higher than the current share price.